Biomedical Engineering Reference
In-Depth Information
Tabl e 1. 1
Commonly considered amino acids
Name
Abbreviations
Molecular weight
Limitations
Glycine
Gly
(or G)
75.07
-
Alanine
Ala
(or A)
89.34
-
Serine
Ser
(or S)
105.10
-
Proline
Pro
(or P)
115.14
-
Valine
Val
(or V)
117.15
-
Threonine
Thr
(or T)
119.12
-
Cysteine
Cys
(or C)
121.16
-
Taurine
Tau
125.15
Only C-terminal
Piroglutamic acid
pGlu
129.10
Only N-terminal
Leucine
Leu
(or L)
131.18
-
Asparagine
Asn
(or N)
132.12
-
Aspartic acid
Asp
(or D)
133.11
-
Glutamine
Gln
(or Q)
146.15
-
Lysine
Lys
(or K)
146.19
-
Glutamic acid
Glu
(or E)
147.13
-
Methionine
Met
(or M)
149.22
-
Histidine
His
(or H)
155.16
-
Phenylalanine
Phe
(or F)
165.16
-
Arginine
Arg
(or R)
174.21
-
Tyrosine
Tyr
(or Y)
181.19
-
There is a large number of possible amino acids, differing in the internal chemi-
cal structure of the radical R, and, therefore, for their functional characteristics and
their molecular weights. Many of them cannot be specified in the genetic code;
hence, the most commonly considered ones generally include the 20 reported in
Tab le 1.1 . Moreover, each amino acid may present one of the many possible modifi-
cations, such as phosphorylation, acetylation and methylation. This would produce
alterations to its standard molecular weight. Note also that the equivalent mass in-
volved in the molecular bindings leads to non-integer values for the amino acid
weights and that the very weight of each amino acid type is not a single fixed value,
but may assume different values depending on the presence of different isotopes of
the various atoms constituting the amino acid. Values reported in Table 1.1 are just
the average masses of the molecules.
An accurate and general sequencing procedure should be able to deal with the
above uncertainties, by taking as part of the problem data the information about:
Which are the components that should be considered as possible for the current
analysis;
Their weight values (in unified atomic mass units u, or daltons);
Possible limitations on the position they can assume within a peptide chain;
The desired numerical precision of the sequencing procedure, set on the basis of
the accuracy of the adopted mass spectrometry device;
And any other incidentally known information.
 
Search WWH ::




Custom Search